Biotech Investing in Longevity Panel 1: Mark Katakowski, Sonia Arrison, Sarah Constantin

First panel of "Biotech Investing in Longevity" Mark Katakowski, Sonia Arrison, Sarah Constantin, in discussion with Allison Duettmann.

Aikora Health and Foresight Institute joined forces to organize a series of talks on biotech investment and longevity. They gathered a curated group of entrepreneurs, scientists, and investors to discuss exciting projects that seek to extend human healthspan, surveying a diversity of novel approaches, and discussing which ambitious goals are realistically within our reach.

This event took place on 1st May 2019 in San Francisco.

Speakers included:

Mark Katakowski, President and CSO of Forever Labs
Reason, CEO of Repair Biotechnologies
Sergio Ruiz, Managing Director of the Methuselah Fund
Doug Ethell, CEO of Leucadia Therapeutics
Vittorio Sebastiano, Scientific Advisory Board Chairman of Turn Biotechnologies
Aubrey de Grey, CSO of SENS Research Foundation
Sonia Arrison, Author of 100 Plus
Sarah Constantin, Founder and Executive Director of The Longevity Research Institute, Founder of Daphnia Labs
Gordon Lithgow, Professor at the Buck Institute for Research on Aging
Mike West, CEO of AgeX Therapeutics

Forever Labs cryopreserves your adult stem cells to create a reservoir of young stem cells for future use. The decline in the number and viability of stem cells contributes to the decline in health associated with aging. Stem cell replacement experiments in mice suggest that young-to-old transplantation of stem cells can extend healthy lifespan. Mark Katakowski co-founded Forever Labs with the goal to bring autologous stem cell replacement therapy to humans.

The Methuselah Fund is designed to accelerate results in the longevity field, extending the healthy human lifespan. They measure their success not just by financial return-on-investments but also by what they call return-on-mission. Their DNA stems from The Methuselah Foundation, which has been working hard during the last 18 years to make 90 the new 50 by 2030.

Repair Biotechnologies is a longevity company with the mission to develop and bring to the clinic therapies that significantly improve human healthspan through targeting the causes of age-related diseases and aging itself. The company currently runs two preclinical development programs: the first for thymus regeneration and immune system restoration, and the second for reversal of atherosclerosis.

Aikora Health connect investors with companies, founders and scientists in the health tech, genomics, and regenerative medicine sectors. Our key focus is on longevity tech with the potential to transform healthcare and human aging. We offer insight and information regarding the biotech and increasingly important longevity space, in addition to matching founders of biotech and longevity companies with funding and strategic partnerships.

Foresight Institute is a leading think tank and public interest organization focused on emerging world-shaping technologies. It was founded in 1986 on a vision of coming revolutions in technology that will bring extraordinary opportunities, as well as unprecedented challenges. Foresight’s mission is to steer towards positive futures, futures of Existential Hope.

Foresight Info and Events: bit.ly/foresightupdates
Foresight Website:
Facebook:
Twitter:
LinkedIn:
Instagram:

Collaborate toward positive futures:

Constantin